Item Type | Name |
Academic Article
|
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
|
Academic Article
|
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
|
Academic Article
|
In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
|
Academic Article
|
Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
|
Academic Article
|
Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.
|
Academic Article
|
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.
|
Academic Article
|
Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
|
Academic Article
|
Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.
|
Academic Article
|
Transgenic models for the study of prostate cancer.
|
Academic Article
|
The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.
|
Academic Article
|
Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.
|
Academic Article
|
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index.
|
Academic Article
|
Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.
|
Academic Article
|
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.
|
Academic Article
|
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
|
Academic Article
|
Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.
|
Academic Article
|
Association of p53 mutations with metastatic prostate cancer.
|
Academic Article
|
Gene therapy for prostate cancer.
|
Academic Article
|
Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer.
|
Academic Article
|
Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
|
Academic Article
|
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.
|
Academic Article
|
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.
|
Academic Article
|
Differential expression of nuclear retinoid receptors in normal and malignant prostates.
|
Academic Article
|
Transforming growth factor beta 1 as a biomarker for prostate cancer.
|
Academic Article
|
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene.
|
Academic Article
|
Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
|
Academic Article
|
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study.
|
Academic Article
|
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
|
Academic Article
|
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression.
|
Academic Article
|
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression.
|
Academic Article
|
In situ gene therapy for prostate cancer: immunomodulatory approaches.
|
Academic Article
|
RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer.
|
Academic Article
|
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
|
Academic Article
|
Cytopathic effect of in situ gene therapy in prostate cancer.
|
Academic Article
|
Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy.
|
Academic Article
|
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer.
|
Academic Article
|
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer.
|
Academic Article
|
Gene therapy for prostate cancer.
|
Academic Article
|
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.
|
Academic Article
|
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
|
Academic Article
|
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
|
Academic Article
|
Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression.
|
Academic Article
|
Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression.
|
Academic Article
|
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
|
Academic Article
|
The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo.
|
Academic Article
|
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients.
|
Academic Article
|
Ethnic and racial differences in prostate stromal estrogen receptor alpha.
|
Academic Article
|
Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.
|
Academic Article
|
Bystin in perineural invasion of prostate cancer.
|
Academic Article
|
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer.
|
Academic Article
|
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
|
Academic Article
|
Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.
|
Academic Article
|
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
|
Academic Article
|
Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
|
Academic Article
|
Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
|
Academic Article
|
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
|
Academic Article
|
Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
|
Academic Article
|
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
|
Academic Article
|
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
|
Academic Article
|
Cancer-related axonogenesis and neurogenesis in prostate cancer.
|
Academic Article
|
The role of caveolin-1 in prostate cancer: clinical implications.
|
Academic Article
|
Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
|
Academic Article
|
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
|
Academic Article
|
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
|
Academic Article
|
Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer.
|
Academic Article
|
Apoptotic index as a biomarker in prostatic intraepithelial neoplasia (PIN) and prostate cancer.
|
Academic Article
|
Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions.
|
Academic Article
|
Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer.
|
Academic Article
|
Elevated expression of caveolin is associated with prostate and breast cancer.
|
Academic Article
|
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
|
Academic Article
|
Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia.
|
Academic Article
|
Elevated caveolin-1 levels in African-American versus white-American prostate cancer.
|
Academic Article
|
Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.
|
Academic Article
|
Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration.
|
Academic Article
|
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.
|
Academic Article
|
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.
|
Academic Article
|
The role of caveolin-1 in androgen insensitive prostate cancer.
|
Academic Article
|
Therapeutic targets for metastatic prostate cancer.
|
Academic Article
|
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
|
Academic Article
|
Experimental oncogene induced prostate cancer.
|
Academic Article
|
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
|
Academic Article
|
High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
|
Academic Article
|
Growth and survival mechanisms associated with perineural invasion in prostate cancer.
|
Academic Article
|
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.
|
Academic Article
|
The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.
|
Academic Article
|
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
|
Academic Article
|
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.
|
Academic Article
|
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
|
Academic Article
|
GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
|
Concept
|
Prostate
|
Concept
|
Prostate-Specific Antigen
|
Academic Article
|
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
|
Academic Article
|
Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
|
Academic Article
|
Transforming growth factor beta 1 transduced mouse prostate reconstitutions: I. Induction of neuronal phenotypes.
|
Academic Article
|
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.
|
Academic Article
|
Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.
|
Academic Article
|
Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer.
|
Academic Article
|
Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.
|
Academic Article
|
Exploiting the complex biology of prostate cancer.
|
Academic Article
|
Gene therapy prolongs PSA doubling time in prostate cancer patients.
|
Academic Article
|
Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.
|
Academic Article
|
Androgen-induced biochemical responses in epithelium lacking androgen receptors: characterization of androgen receptors in the mesenchymal derivative of urogenital sinus.
|
Academic Article
|
Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer.
|
Academic Article
|
Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
|
Academic Article
|
Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer.
|
Academic Article
|
Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines.
|
Academic Article
|
Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice.
|
Academic Article
|
Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
|
Academic Article
|
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
|
Academic Article
|
In situ gene therapy for prostate cancer.
|
Academic Article
|
Metastasis-related genes in prostate cancer: the role of caveolin-1.
|
Academic Article
|
Metastasis-related genes in prostate cancer.
|
Academic Article
|
Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells.
|
Academic Article
|
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
|
Academic Article
|
Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma.
|
Academic Article
|
Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.
|
Academic Article
|
Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
|
Academic Article
|
Gene-modified bone marrow cell therapy for prostate cancer.
|
Academic Article
|
Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells.
|
Academic Article
|
Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.
|
Academic Article
|
Mouse prostate reconstitution: An in vivo transgenic gland model system.
|
Academic Article
|
Anti-caveolin-1 antibodies as anti-prostate cancer therapeutics.
|
Academic Article
|
Systemic GLIPR1-?TM protein as a novel therapeutic approach for prostate cancer.
|
Academic Article
|
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.
|
Academic Article
|
A new mouse model for prostatic hyperplasia: induction of adult prostatic overgrowth by fetal urogenital sinus implants.
|
Academic Article
|
Extraction of nuclear androgen receptors by sodium molybdate from normal rat prostates and prostatic tumors.
|
Academic Article
|
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
|
Academic Article
|
Transforming growth factor beta 1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin.
|
Academic Article
|
Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.
|
Academic Article
|
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells.
|
Academic Article
|
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
|
Academic Article
|
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
|
Academic Article
|
Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease.
|
Academic Article
|
Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
|
Academic Article
|
Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.
|
Academic Article
|
Prostate-specific antitumor activity by probasin promoter-directed p202 expression.
|
Academic Article
|
Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathway.
|
Academic Article
|
Perifosine induces differentiation and cell death in prostate cancer cells.
|
Academic Article
|
Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.
|
Academic Article
|
Grappling with the androgen receptor: a new approach for treating advanced prostate cancer.
|
Academic Article
|
Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.
|
Academic Article
|
Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.
|
Academic Article
|
Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer.
|
Academic Article
|
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.
|
Academic Article
|
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.
|
Academic Article
|
GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancer.
|
Academic Article
|
Growth factors and oncogenes in prostate cancer.
|
Academic Article
|
Tissue interactions in prostate development: roles of sex steroids.
|
Academic Article
|
DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
|
Academic Article
|
Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.
|
Academic Article
|
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.
|
Academic Article
|
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
|
Academic Article
|
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.
|
Academic Article
|
Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy.
|
Academic Article
|
Regulation of apoptosis in prostatic disease.
|
Academic Article
|
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
|
Academic Article
|
LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
|
Academic Article
|
Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.
|
Academic Article
|
Tissue interactions and prostatic growth: a new mouse model for prostatic hyperplasia.
|
Academic Article
|
Epithelial-mesenchymal interactions in prostatic development. II. Biochemical observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder.
|
Academic Article
|
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.
|
Academic Article
|
Recent advances in the development of animal and cell culture models for prostate cancer research A minireview.
|
Academic Article
|
Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer.
|
Academic Article
|
DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
|
Academic Article
|
Environmental and psycho-social factors related to prostate cancer risk in the Chinese population: a case-control study.
|
Academic Article
|
New targets for resistant prostate cancer.
|
Academic Article
|
Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.
|
Academic Article
|
GLIPR1-?TM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.
|
Academic Article
|
Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer.
|
Academic Article
|
Regulation of apoptosis in prostatic disease
|
Academic Article
|
Combination gene therapy with adenoviral vector-mediated HSV-tk + GCV and IL-12 in an orthotopic mouse model for prostate cancer
|
Academic Article
|
Transforming growth factor β1 as a biomarker for prostate cancer
|
Academic Article
|
DNA damage response and prostate cancer
|
Academic Article
|
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer
|
Academic Article
|
Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer
|
Academic Article
|
Mesenchymal-epithelial interactions and transforming growth factor-β expression during mouse prostate morphogenesis
|
Academic Article
|
Combined tumor suppressor defects characterize clinically defined aggressive variant prostate cancers
|
Academic Article
|
Strategies for prostate cancer gene therapy
|
Academic Article
|
Tissue and cell-cell interactions in prostate cancer progression
|
Academic Article
|
Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance
|
Academic Article
|
Current status and future aspects of prostate cancer gene therapy - Will it be a revolutionary therapy?
|
Academic Article
|
Identification of a novel prostate cancer biomarker, caveolin-1
|
Academic Article
|
The Molecular Taxonomy of Primary Prostate Cancer
|
Academic Article
|
Erratum to GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancer [Cancer Cell 24, July 8, (2013) 11-13]
|
Academic Article
|
Recent advances in the development of animal and cell culture models for prostate cancer research
|
Academic Article
|
Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer.
|
Academic Article
|
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.
|
Academic Article
|
Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy.
|
Academic Article
|
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers.
|
Academic Article
|
Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance.
|
Academic Article
|
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer.
|
Academic Article
|
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.
|
Academic Article
|
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
|
Academic Article
|
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer.
|
Academic Article
|
Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer.
|
Academic Article
|
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.
|
Academic Article
|
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models.
|
Academic Article
|
ER stress in prostate cancer: A therapeutically exploitable vulnerability?
|
Academic Article
|
Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned.
|
Academic Article
|
N-MYC regulation of DNA damage response in neuroendocrine prostate cancer: mechanistic insight and novel combination therapy approaches.
|
Grant
|
Mechanisms of Metastasis in Experimental Prostate Cancer
|
Grant
|
Lipidomics-based biomarkers for risk of progression in early prostate cancer
|
Grant
|
MD Anderson Cancer Center Prostate Cancer SPORE
|
Grant
|
MESENCHYMAL GROWTH FACTOR ACTIVITIES IN MOUSE BPH MODEL
|
Grant
|
SPORE in Prostate Cancer
|
Grant
|
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer
|
Academic Article
|
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.
|
Academic Article
|
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance.
|
Academic Article
|
Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans.
|
Academic Article
|
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.
|
Academic Article
|
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial.
|
Academic Article
|
Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
|
Academic Article
|
Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.
|
Academic Article
|
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer.
|
Academic Article
|
Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.
|
Grant
|
Prostate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy
|
Academic Article
|
Considering the potential for gene-based therapy in prostate cancer.
|
Academic Article
|
Optimizing the diagnosis and management of ductal prostate cancer.
|
Academic Article
|
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancer.
|
Academic Article
|
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer.
|
Academic Article
|
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate Cancer.
|
Academic Article
|
Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
|
Academic Article
|
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.
|
Grant
|
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
|